Facebook
Twitter
Telegram
Report an ErrorHelius Medical Technologies Balance Sheet 2011-2024 | HSDT
Annual Balance Sheet Helius Medical Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-5.12 M | -14.4 M | - | -3.24 M | -4.82 M | -25.6 M | -5.56 M | -2.64 M | -419 K | -9 | - | - | - |
Long Term Debt |
12 K | 56 K | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
45 K | 54 K | 3 K | 59 K | 172 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 252 K | 710 K | - | - | 1.73 M | 1.58 M | - | - | - | - |
Total Current Liabilities |
1.88 M | 1.99 M | 2.65 M | 2.42 M | 3.8 M | 18 M | 14.3 M | 6.89 M | 1.2 M | - | - | - | - |
Total Liabilities |
5.34 M | 9.14 M | 2.85 M | 2.68 M | 4.51 M | 18 M | 14.3 M | 4.06 M | 2.78 M | - | - | - | - |
Deferred Revenue |
- | - | 148 K | 281 K | 430 K | - | 233 K | - | - | - | - | - | - |
Retained Earnings |
-160 M | -151 M | -137 M | -119 M | -105 M | -95 M | -66.4 M | -26.3 M | -18.5 M | - | - | - | - |
Total Assets |
7.69 M | 17.3 M | 14.1 M | 6.55 M | 10.3 M | 27.8 M | 6.81 M | 4.04 M | 1.22 M | 9 | - | - | - |
Cash and Cash Equivalents |
5.18 M | 14.5 M | 11 M | 3.33 M | 5.46 M | 25.6 M | 5.56 M | 2.67 M | 4.35 M | 16 K | - | - | - |
Book Value |
2.35 M | 8.15 M | 11.3 M | 3.87 M | 5.84 M | 9.85 M | -7.49 M | -16.2 K | -1.56 M | 9 | - | - | - |
Total Shareholders Equity |
2.35 M | 8.15 M | 11.3 M | 3.87 M | 5.84 M | 9.85 M | -7.49 M | -3.44 M | -2.06 M | -268 K | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Helius Medical Technologies
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 12 K | 23 K | 35 K | 46 K | 56 K | 70 K | 83 K | 99 K | - | - | - | 16 K | 32 K | 32 K | 32 K | 32 K | 465 K | 465 K | 465 K | 465 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.77 M | 5.34 M | 5.83 M | 6.18 M | 7.69 M | 9.14 M | 5.9 M | 2.04 M | 2.49 M | 2.85 M | 2.84 M | 2.35 M | 2.77 M | 2.68 M | 2.68 M | 2.68 M | 2.68 M | 4.51 M | 4.51 M | 4.51 M | 4.51 M | 18 M | 18 M | 18 M | 18 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 6.89 M | 6.89 M | 6.89 M | 6.89 M | 7.31 M | 1.86 M | 3.84 M | 2.78 M | - | - | - | 584 K | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | 26 K | 28 K | 29 K | 148 K | 252 K | 290 K | 284 K | 281 K | 281 K | 281 K | 281 K | 430 K | 430 K | 430 K | 430 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-162 M | -160 M | -159 M | -155 M | -154 M | -151 M | -146 M | -145 M | -141 M | -137 M | -133 M | -128 M | -122 M | -119 M | -119 M | -119 M | -119 M | -105 M | -105 M | -105 M | -105 M | -95 M | -95 M | -95 M | -95 M | -66.4 M | -66.4 M | -66.4 M | -66.4 M | -38.3 M | -38.3 M | -38.3 M | -38.3 M | -22.5 M | -20 M | -21.8 M | -19.4 M | - | - | - | -9.59 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
5.76 M | 7.69 M | 8.85 M | 10.8 M | 13.8 M | 17.3 M | 18.9 M | 6.55 M | 9.62 M | 14.1 M | 7.88 M | 10.7 M | 14.7 M | 6.55 M | 6.55 M | 6.55 M | 6.55 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 27.8 M | 27.8 M | 27.8 M | 27.8 M | 6.81 M | 6.81 M | 6.81 M | 6.81 M | 3.45 M | 3.45 M | 3.45 M | 3.45 M | 5.26 M | 719 K | 1.43 M | 1.22 M | - | - | - | 316 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
3.64 M | 5.18 M | 6.6 M | 8.6 M | 11.3 M | 14.5 M | 16.7 M | 3.27 M | 6.31 M | 11 M | 4.7 M | 7.42 M | 11.4 M | 3.33 M | 3.33 M | 3.33 M | 3.33 M | 5.46 M | 5.46 M | 5.46 M | 5.46 M | 25.6 M | 25.6 M | 25.6 M | 25.6 M | 5.56 M | 5.56 M | 5.56 M | 7.67 M | 2.67 M | 6.17 M | 7.97 M | 2.64 M | 4.35 M | 192 K | 972 K | 419 K | 2.91 M | 2.91 M | 5 M | 7.03 M | - | - | - | 217 | - | - | - | - | - | - | - | - |
Book Value |
1.99 M | 2.35 M | 3.02 M | 4.57 M | 6.07 M | 8.15 M | 13 M | 4.5 M | 7.13 M | 11.3 M | 5.04 M | 8.37 M | 11.9 M | 3.87 M | 3.87 M | 3.87 M | 3.87 M | 5.84 M | 5.84 M | 5.84 M | 5.84 M | 9.85 M | 9.85 M | 9.85 M | 9.85 M | -7.49 M | -7.49 M | -7.49 M | -7.49 M | -3.44 M | -3.44 M | -3.44 M | -3.44 M | -2.06 M | -1.14 M | -2.41 M | -1.56 M | - | - | - | -268 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
1.99 M | 2.35 M | 3.02 M | 4.57 M | 6.07 M | 8.15 M | 13 M | 4.5 M | 7.13 M | 11.3 M | 5.04 M | 8.37 M | 11.9 M | 3.87 M | 3.87 M | 3.87 M | 3.87 M | 5.84 M | 5.84 M | 5.84 M | 5.84 M | 9.85 M | 9.85 M | 9.85 M | 9.85 M | -7.49 M | -7.49 M | -7.49 M | -7.49 M | -3.44 M | -3.44 M | -3.44 M | -3.44 M | -2.06 M | -1.14 M | -2.41 M | -1.56 M | - | - | - | -268 K | - | - | - | -7.85 K | - | - | - | - | - | - | - | - |
All numbers in USD currency